title: L-arginine depletion by arginase reduces nitric oxide production in endotoxic shock: an electron paramagnetic resonance study.
abstract: Nitric oxide (NO) synthesis was measured in the liver, lung, spleen and kidney of lipopolysaccharide-treated male rats using the nitric oxide spin trap, iron (II)-diethyldithiocarbamate (FeDETC2). Nitric oxide formation in vivo was determined by the increase in intensity of the characteristic triplet hyperfine EPR spectrum of [NO-FeDETC2]. Intravenous bovine liver arginase, at a dose which completely depleted circulating arginine, significantly reduced the formation of nitric oxide in these tissues. The general decrease in NO levels was confirmed by the decrease in plasma nitrite levels. These results directly demonstrate that NO formation in endotoxic shock depends on extracellular arginine; depletion of plasma arginine may be a useful therapeutic strategy.
authors.affiliation: Department of Histopathology, St. Marys Hospital Medical School, Imperial College of Science, Technology and Medicine, London, UK.
authors.forename: A J
authors.initials: AJ
authors.lastname: Bune
authors.forename: J K
authors.initials: JK
authors.lastname: Shergill
authors.forename: R
authors.initials: R
authors.lastname: Cammack
authors.forename: H T
authors.initials: HT
authors.lastname: Cook
mesh_terms: D000818:Animals; D001119:Arginase / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D001120:Arginine / Q000031:analogs & derivatives / Q000097:blood* / Q000494:pharmacology; D004050:Ditiocarb / Q000031:analogs & derivatives / Q000378:metabolism; D004578:Electron Spin Resonance Spectroscopy; D005296:Ferrous Compounds / Q000378:metabolism; D007668:Kidney / Q000187:drug effects / Q000378:metabolism; D008070:Lipopolysaccharides / Q000633:toxicity; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008168:Lung / Q000187:drug effects / Q000378:metabolism; D008297:Male; D009569:Nitric Oxide / Q000096:biosynthesis*; D051381:Rats; D011917:Rats, Inbred Lew; D012772:Shock, Septic / Q000378:metabolism*; D013154:Spleen / Q000187:drug effects / Q000378:metabolism; D019323:omega-N-Methylarginine
chemical_list: D005296:Ferrous Compounds; D008070:Lipopolysaccharides; C085124:diethyldithiocarbamate iron(II); D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D001120:Arginine; D004050:Ditiocarb; D001119:Arginase